EPISODE · Nov 27, 2019 · 47 MIN
Breast, Uterine and Ovarian Cancers
from Gresham College Lectures · host Gresham College
This lecture will consider the treatment and prevention of common cancers in women. The outlook for those with breast cancer and uterine cancer have substantially improved in the last three decades, and the great majority with the diagnosis will be alive and well a decade later. The outlook for ovarian cancer is less good although improving. This lecture will consider the evolving treatments, including the importance of genetic markers and hormonal treatments and approaches to prevention and screening.A lecture by Chris Whitty 27 NovemberThe transcript and downloadable versions of the lecture are available from the Gresham College website: https://www.gresham.ac.uk/lectures-and-events/breast-uterine-ovarian-cancersGresham College has been giving free public lectures since 1597. This tradition continues today with all of our five or so public lectures a week being made available for free download from our website. There are currently over 2,000 lectures free to access or download from the website.Website: http://www.gresham.ac.uk Twitter: http://twitter.com/GreshamCollege Facebook: https://www.facebook.com/greshamcollege Instagram: http://www.instagram.com/greshamcollege Support the show
What this episode covers
This lecture will consider the treatment and prevention of common cancers in women. The outlook for those with breast cancer and uterine cancer have substantially improved in the last three decades, and the great majority with the diagnosis will be alive and well a decade later. The outlook for ovarian cancer is less good although improving. This lecture will consider the evolving treatments, including the importance of genetic markers and hormonal treatments and approaches to prevention an...
NOW PLAYING
Breast, Uterine and Ovarian Cancers
No transcript for this episode yet
Similar Episodes
May 31, 2026 ·25m
May 31, 2026 ·30m
May 31, 2026 ·57m
May 31, 2026 ·32m
May 31, 2026 ·29m
May 31, 2026 ·37m